IL1F10 and posterior cortical atrophy: Furthermore, the PCa patients in TNM stage III exhibited significantly higher IL-38 expression than those in stages I and II (Figure 1E, P = 0.0262; P=0.0349), Similarly, the PCa patients in prognostic group III showed significantly higher IL-38 expression than those in groups I and II (Figure 1F, P = 0.0017; P=0.0452).